… S: 14S, 21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell
amelioration of renal ischemia/reperfusion injury. Stem Cells Dev 2012; 21: 1187–1199. 97 …

… Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal
stem cells on the development of renal ischemia-reperfusion injury in mice. Am J Physiol …

… Current treatment options for acute renal failure … Renal ischemia-reperfusion injury (I/R
injury) is one of the most common causes of ARF. I/R injury is characterized by alterations in cell …

… which suppress injury and maintain tissue functions perturbed by ischemia-reperfusion.
This … mechanisms underlying stem cell protection in diverse forms of ischemia-reperfusion. …

… with mesenchymal stem cells (iMSCs) or iMSC-derived exosome (iExo) on the mRNA
levels of antioxidant and inflammatory genes in renal ischemia reperfusion (I/R) injury mouse …

… Ischemia and reperfusion injury (I/R) is the major cause of acute renal failure (ARF) with high
… , we investigated the use of stem cell therapy to modulate inflammation in a renal I/R model. …

… and 2 after kidney ischemia/reperfusion injury and examined the kidney 2.5, 3, 5, and 7 days
after injury (Figure 1); many recruited HSPCs could be detected in the kidney parenchyma. …

… Also a decrease at cell numbers and prevention of spleen cells … of stem cells alone or in
combination with FTY720 to promote early kidney recovery after ischemia-reperfusion injury. …

… of umbilical cord-mesenchymal stem cells (UC-MSCs) labelled with enhanced green
fluorescent protein (eGFP) in the repair of renal ischaemia-reperfusion (I/R) injury, to determine the …

… Acute kidney injury (AKI) is an emerging global healthcare issue without … renal
ischemia-reperfusion (I/R) injury. Hypoxic mesenchymal stem cells (HMSCs) represent an innovative …